Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Functional Characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 Ubiquitin Ligases in Tumorigenesis

The Role Of Apc E3 Ubiquitin Ligase Complex In Tumorigenesis

Insights into Apc/C: from Cellular Function to Diseases and Therapeutics

The Function of Apc/C-Cdh1 in Cell Cycle and Beyond

Review the Function of APC/C Cdh1 in Cell Cycle and Beyond

The function of APC/C<sup>Cdh1 </sup>in cell cycle and beyond

Genetically Engineered Mouse Models for Functional Studies of SKP1-CUL1-F-box-protein (SCF) E3 Ubiquitin Ligases

Targeting Cdc20 As a Novel Cancer Therapeutic Strategy.

Modeling potent pathways for APC/C inhibition: pivotal roles for MCC and BubR1

Relationship of Ubiquitin-Ligases APC/C and SCF Complex to Cancer

Functional analysis of APC-Cdh1

APC/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1/S transition

Ubiquitin ligases: cell-cycle control and cancer

A dual‐kinase mechanism controls APC phosphorylation and dissociation from microtubules during mitosis

Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.

Apc/C Is Essential For Hematopoiesis And Impaired In Aplastic Anemia

The Structure and Function of SCF and APC/C

Deletion of a core APC/C component reveals APC/C function in regulating neuronal USP1 levels and morphology

Use of Apc(Min/+) Mouse Model in the Studies of Intestinal Tumors

The Arabidopsis Anaphase‐Promoting Complex/Cyclosome Subunit 1 is Critical for Both Female Gametogenesis and EmbryogenesisF

A comparative study of the cryo-EM structures of and human anaphase-promoting complex/cyclosome (APC/C)